Tag: dry age related macular degeneration (amd) market size

2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

What Factors Are Propelling the Market Growth of theDry Age Related Macular Degeneration (AMD) Market from 2025 to 2034?

The growing geriatric population is expected to drive the growth of the dry age-related macular degeneration (AMD) market. As medical advancements and improved chronic disease management have increased life expectancy, the number of older adults is steadily rising. Dry AMD, a leading cause of vision impairment among the elderly, provides targeted treatments aimed at slowing disease progression and preserving vision. With 57.8 million adults aged 65 and older in the U.S. in 2022, representing 17.3% of the total population, the growing geriatric demographic presents a growing market for AMD treatments.

Get Your Free Sample Report Now – Explore Exclusive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21176&type=smp

What is the Predicted Annual Growth Rate of theDry Age Related Macular Degeneration (AMD) Market Impact Industry Trends by 2034?

The dry age-related macular degeneration (AMD) market is experiencing steady growth, increasing from $4.49 billion in 2024 to $4.90 billion in 2025 at a CAGR of 9.1%. The historical growth factors include a rising aging population, an increased prevalence of chronic diseases, growing awareness of eye health, a rising number of clinical trials focused on dry AMD, and a growing demand for minimally invasive treatments.

The dry age-related macular degeneration (AMD) market is projected to experience significant growth, reaching $6.86 billion by 2029 at a CAGR of 8.8%. This expansion will be driven by the emergence of novel therapies, increased healthcare spending, rising use of laser photocoagulation therapy, progress in genetic research, and a heightened focus on personalized medicine. Key trends include advancements in diagnostic technologies, the growing adoption of teleophthalmology, cutting-edge treatment options, regulatory approvals, and the launch of new products.

You can Directly Purchase the Report Here:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21176

How Are Market Trends and Innovations Revolutionizing theDry Age Related Macular Degeneration (AMD) Industry in Recent Times?

In the dry age-related macular degeneration (AMD) market, companies are innovating with light delivery systems to activate retinal cells and slow disease progression. For example, in January 2024, LumiThera Inc., a US-based medical device company, launched the Valeda Light Delivery System for treating dry AMD. This FDA-authorized photobiomodulation (PBM) therapy uses multi-wavelength light (590 nm, 660 nm, and 850 nm) to target retinal cells, offering a non-invasive treatment option. LumiThera also initiated the EUROLIGHT registry study to gather long-term data on the system’s effectiveness in improving vision in dry AMD patients.

Which Key Market Players Are Shaping the Future and Growth of theDry Age Related Macular Degeneration (AMD) Market?

Major companies operating in the dry age related macular degeneration (AMD) market are F Hoffmann-La Roche Ltd., Novartis AG, Bayer AG, Amgen Inc., Biogen Inc., Astellas Pharma Inc., Bausch Health Companies Inc., Lupin Ltd., Santen Pharmaceuticals Inc., Biocon Ltd., Alimera Sciences Inc., Apellis Pharmaceuticals Inc., Belite Bio Inc., Axol Bioscience Ltd., Alkeus Pharmaceuticals Inc., Kubota Holdings Co., Ribomic Inc., Eyestem Research Pvt. Ltd., LumiThera Inc., Adverum Biotechnologies Inc.

Order Your Report Now For A Swift Delivery:

https://www.thebusinessresearchcompany.com/report/dry-age-related-macular-degeneration-amd-global-market-report

What Are the Core Segments of the Dry Age Related Macular Degeneration (AMD) Market, and How Do They Contribute to Growth?

The dry age related macular degeneration (AMD) market covered in this report is segmented –

1) By Stages: Early Age-Related Macular Degeneration, Intermediate Age-Related Macular Degeneration, Late Age-Related Macular Degeneration

2) By Age Group: Above 75 Years, Above 60 Years, Above 40 Years

3) By Route Of Administration: Oral, Injectables

4) By End Users: Hospitals And Clinics, Diagnostic Centers, Academic And Research Institutes

Subsegments:

1) By Early Age-Related Macular Degeneration: Drusen Accumulation, Retinal Pigment Epithelium Changes

2) By Intermediate Age-Related Macular Degeneration: Larger Drusen Deposits, Increased Pigmentary Abnormalities

3) By Late Age-Related Macular Degeneration: Geographic Atrophy, Central Vision Loss

Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

https://www.thebusinessresearchcompany.com/customise?id=21176&type=smp

What Regions Are Dominating the Dry Age Related Macular Degeneration (AMD) Market Growth?

North America was the largest region in the dry age-related macular degeneration (AMD) market in 2024. The regions covered in the dry age related macular degeneration (AMD) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Reports Similar to the Global Dry Age Related Macular Degeneration (AMD) Market 2025, By The Business Research Company:

Hyperuricemia Drugs Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/hyperuricemia-drugs-global-market-report

Gout Therapeutics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/gout-therapeutics-global-market-report

Smart Insulin Pens Global Market Report 2025

https://thebusinessresearchcompany.com/report/smart-insulin-pens-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Get 20% off on Global Market Reports until March 31st! Use code FY25SAVE at checkout.

How has the dry age related macular degeneration (amd) market grown over the years?

In recent years, the market size for dry age related macular degeneration (AMD) has witnessed robust growth. The market is forecasted to expand from $4.49 billion in 2024 to $4.90 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 9.1%. The surge during the historic period can be traced back to an increasing elderly population, higher incidence of chronic diseases, heightened awareness about ocular health, a rise in clinical trials centered around dry AMD, and greater demand for less invasive procedures.

What Is the forecasted market size and growth rate for the dry age related macular degeneration (amd) market?

The market for dry age related macular degeneration (AMD) is predicted to experience significant expansion in the coming years. It is projected to reach a value of $6.86 billion in 2029, growing at a compound annual growth rate (CAGR) of 8.8%. Factors such as the introduction of innovative therapies, an increase in healthcare spending, growing use of laser photocoagulation therapy, breakthroughs in genetic research and an emphasis on personalized treatment are likely to drive this growth within the forecast period. The period is also expected to witness trends such as advancements in diagnostic technologies, wider adoption of teleophthalmology, state-of-the-art treatments, approval of products, and the launch of new products.

Get your dry age related macular degeneration (amd) market report here!

https://www.thebusinessresearchcompany.com/report/dry-age-related-macular-degeneration-amd-global-market-report

What are the major factors driving growth in the dry age related macular degeneration (amd) market?

The surge in the elderly population is anticipated to drive the expansion of the dry age-related macular degeneration (AMD) market. The term “geriatric population” refers to individuals who are typically 65 years old or above. The escalation in the number of older adults is due to several contributing factors such as advancements in medical technology, successful handling of chronic illnesses, increased life expectancy, and elevated quality of geriatric care. Dry age-related macular degeneration (AMD) benefits these seniors by offering custom-made treatments and management strategies designed to decelerate the disease’s advance, conserve sight and enhance the quality of life for those affected by this condition. For example, as per the reports circulated by the National Council on Aging, based in the U.S, in 2022, an estimated 57.8 million adults were aged 65 or above, accounting for 17.3% of the total U.S population. This showcased an uptick from 16.9% in 2021. Hence, the increasing geriatric population is projected to fuel the growth of the dry age-related macular degeneration (AMD) market.

What key areas define the segmentation of the global dry age related macular degeneration (amd) Market?

The dry age related macular degeneration (AMD) market covered in this report is segmented –

1) By Stages: Early Age-Related Macular Degeneration, Intermediate Age-Related Macular Degeneration, Late Age-Related Macular Degeneration

2) By Age Group: Above 75 Years, Above 60 Years, Above 40 Years

3) By Route Of Administration: Oral, Injectables

4) By End Users: Hospitals And Clinics, Diagnostic Centers, Academic And Research Institutes

Subsegments:

1) By Early Age-Related Macular Degeneration: Drusen Accumulation, Retinal Pigment Epithelium Changes

2) By Intermediate Age-Related Macular Degeneration: Larger Drusen Deposits, Increased Pigmentary Abnormalities

3) By Late Age-Related Macular Degeneration: Geographic Atrophy, Central Vision Loss

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21176&type=smp

What are the top market players propelling the growth of the dry age related macular degeneration (amd) industry?

Major companies operating in the dry age related macular degeneration (AMD) market are F Hoffmann-La Roche Ltd., Novartis AG, Bayer AG, Amgen Inc., Biogen Inc., Astellas Pharma Inc., Bausch Health Companies Inc., Lupin Ltd., Santen Pharmaceuticals Inc., Biocon Ltd., Alimera Sciences Inc., Apellis Pharmaceuticals Inc., Belite Bio Inc., Axol Bioscience Ltd., Alkeus Pharmaceuticals Inc., Kubota Holdings Co., Ribomic Inc., Eyestem Research Pvt. Ltd., LumiThera Inc., Adverum Biotechnologies Inc.

What are the key trends shaping the future of the dry age related macular degeneration (amd) market?

Primary businesses in the dry age-related macular degeneration (AMD) sector are concentrating on the creation of novel, advanced technologies and remedies, such as light delivery systems. These are intended to target and stimulate retinal cells, potentially reducing the progression of the disease. Light delivery systems pertain to technologies crafted for the transmission of light in therapeutic procedures, most notably in medical treatments. For instance, LumiThera Inc., a medical device firm based in the US, unveiled photobiomodulation (PBM) for dry AMD through the Valeda Light Delivery System in January 2024. This marked the first therapy sanctioned by the FDA specifically designed to counter vision loss in patients afflicted by dry AMD, a disease with currently restricted treatment alternatives. LumiThera initiated the EUROLIGHT registry study to compile long-term data on patient outcomes post-treatment with the Valeda system. The Valeda system uses a light delivery procedure with three specific wavelengths (590 nm, 660 nm, and 850 nm). This non-invasive therapy can be delivered either through an open or shut eyelid and usually necessitates nine sessions over a span of three to four weeks.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21176

What regions are dominating the dry age related macular degeneration (amd) market growth?

North America was the largest region in the dry age-related macular degeneration (AMD) market in 2024. The regions covered in the dry age related macular degeneration (AMD) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Similar Reports By The Business Research Company:

Hyperuricemia Drugs Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/hyperuricemia-drugs-global-market-report

Gout Therapeutics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/gout-therapeutics-global-market-report

Smart Insulin Pens Global Market Report 2025

https://thebusinessresearchcompany.com/report/smart-insulin-pens-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

How Rapidly is the Dry Age Related Macular Degeneration (AMD) Market Expected to Expand Between 2025 and 2034 Based on Current Trends?

The market size for dry age-related macular degeneration (AMD) has seen robust growth in the recent past. The market, which is expected to be $4.49 billion in 2024, is projected to increase to $4.90 billion in 2025, representing a compound annual growth rate (CAGR) of 9.1%. The substantial growth during the historical period is tied to factors such as an increasing elderly population, a higher incidence of chronic illnesses, a heightened awareness about eye health, an uptick in clinical trials centered on dry AMD, and a rising demand for minimally invasive procedures.

In the coming years, the dry age related macular degeneration (AMD) market is projected to witness considerable growth, culminating in a worth of $6.86 billion in 2029 with a compound annual growth rate of 8.8%. This increase during the forecasting period is due to several factors such as the advent of innovative therapies, increased expenditure in healthcare, higher usage of laser photocoagulation therapy, progressions in genetic study and the rising emphasis on tailor-made medication. The forecast period will also see trends like advancements in diagnostic technology, wider adoption of teleophthalmology, technical advancements in treatment, product approvals and the introduction of new products.

Which Drivers Are Expected to Have the Greatest Impact on the Dry Age Related Macular Degeneration (AMD) Market’s Growth?

The anticipated expansion of the dry age-related macular degeneration (AMD) market is closely tied to the rising number of elderly people in society. Generally, the geriatric population encapsulates those who are 65 years and over. This demographic is expanding as a result of multiple nascent factors such as enhanced medical technology, improved management of long-term illnesses, increased longevity, and advancements in elderly care. The dry AMD market benefits this ageing population by featuring precise treatment plans and management strategies, designed to mitigate the disease’s progression, protect vision and enhance life quality for older adults with this disease. For example, as documented by the National Council on Aging, an American organisation, in 2022, approximately 57.8 million seniors aged 65 and older were living in the US, making up 17.3% of the country’s entire population. This shows an increase from 16.9% in 2021. As a result, the burgeoning geriatric population is poised to fuel the expansion of the dry age-related macular degeneration (AMD) market.

Explore Comprehensive Insights Into The Global Dry Age Related Macular Degeneration (AMD) Market With A Free Sample Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21176&type=smp

Which key players are shaping the future of the Dry Age Related Macular Degeneration (AMD) market?

Major companies operating in the dry age related macular degeneration (AMD) market are F Hoffmann-La Roche Ltd., Novartis AG, Bayer AG, Amgen Inc., Biogen Inc., Astellas Pharma Inc., Bausch Health Companies Inc., Lupin Ltd., Santen Pharmaceuticals Inc., Biocon Ltd., Alimera Sciences Inc., Apellis Pharmaceuticals Inc., Belite Bio Inc., Axol Bioscience Ltd., Alkeus Pharmaceuticals Inc., Kubota Holdings Co., Ribomic Inc., Eyestem Research Pvt. Ltd., LumiThera Inc., Adverum Biotechnologies Inc.

How Are the Latest Trends Influencing the Growth of the Dry Age Related Macular Degeneration (AMD) Market?

Leading companies in the dry age-related macular degeneration (AMD) market are focusing on the creation of innovative technology and treatments such as light delivery systems, to target and stimulate retinal cells, potentially reducing the progression of the disease. Light delivery systems are technologies engineered to convey light for therapeutic uses, especially in medical treatments. For example, in January 2024, LumiThera Inc., a medical device company based in the US, introduced photobiomodulation (PBM) for dry age-related macular degeneration (AMD) using the Valeda Light Delivery System. This marks the first therapy authorized by the FDA to treat vision loss in patients with dry AMD, a condition that presently has restricted treatment choices. LumiThera initiated the EUROLIGHT registry study to compile long-term patient outcome data following treatment with the Valeda system. The Valeda system leverages a multi-wavelength light delivery method using three specific wavelengths (590 nm, 660 nm, and 850 nm). This non-intrusive treatment can be delivered through an open or closed eyelid and generally necessitates nine sessions over a span of three to four weeks.

Secure Your Global Dry Age Related Macular Degeneration (AMD) Market Report Now for Fast and Efficient Delivery!

https://www.thebusinessresearchcompany.com/report/dry-age-related-macular-degeneration-amd-global-market-report

What Are the Major Segments of the Dry Age Related Macular Degeneration (AMD) Market and Their Role in Driving Growth?

The dry age related macular degeneration (AMD) market covered in this report is segmented –

1) By Stages: Early Age-Related Macular Degeneration, Intermediate Age-Related Macular Degeneration, Late Age-Related Macular Degeneration

2) By Age Group: Above 75 Years, Above 60 Years, Above 40 Years

3) By Route Of Administration: Oral, Injectables

4) By End Users: Hospitals And Clinics, Diagnostic Centers, Academic And Research Institutes

Subsegments:

1) By Early Age-Related Macular Degeneration: Drusen Accumulation, Retinal Pigment Epithelium Changes

2) By Intermediate Age-Related Macular Degeneration: Larger Drusen Deposits, Increased Pigmentary Abnormalities

3) By Late Age-Related Macular Degeneration: Geographic Atrophy, Central Vision Loss

What Regions Are At the Forefront of Dry Age Related Macular Degeneration (AMD) Market Expansion?

North America was the largest region in the dry age-related macular degeneration (AMD) market in 2024. The regions covered in the dry age related macular degeneration (AMD) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

How Can We Define the Dry Age Related Macular Degeneration (AMD) Market and Its Key Components?

Dry age related macular degeneration (AMD) refers to a progressive eye condition characterized by the gradual deterioration of the macula, the central part of the retina, leading to blurred central vision. They are used for managing and slowing the progression of the disease through treatments like vitamins, nutritional supplements, and emerging pharmaceutical therapies.

Browse Through More Similar Reports By The Business Research Company:

Hyperuricemia Drugs Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/hyperuricemia-drugs-global-market-report

Gout Therapeutics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/gout-therapeutics-global-market-report

Smart Insulin Pens Global Market Report 2025

https://thebusinessresearchcompany.com/report/smart-insulin-pens-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: